To explore the correlation between MyD88 expression in the mouse liver and development of NAFLD-related HCC, we used C57BL/6 mouse models of NAFLD and HFD-related HCC. This evidence concerns the gene MYD88 and metabolic dysfunction-associated steatotic liver disease.